Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05021640 · ClinicalTrials.gov registry record · Phase 1
Study of DCR-AUD in Healthy Volunteers
A Phase 1 study, sponsored by Dicerna Pharmaceuticals, Inc., a Novo Nordisk company.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
NCT05021640 is a Phase 1 study that has completed, run by Dicerna Pharmaceuticals, Inc., a Novo Nordisk company. The registered enrollment target is 36 participants.
The verdict
NCT05021640, a Phase 1 study, has completed, sponsored by Dicerna Pharmaceuticals, Inc., a Novo Nordisk company.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
Study Summary
DCR-AUD will be evaluated for safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy volunteers.
Interventions
- DRUG DCR-AUD
- DRUG Placebo for DCR-AUD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2021-09-21 |
| Est. Completion | 2022-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05021640
The ClinicalTrials.gov registry entry for NCT05021640 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dicerna Pharmaceuticals, Inc., a Novo Nordisk company, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which DCR-AUD is the first listed.
NCT05021640 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05021640 about?
NCT05021640 is a clinical study titled "Study of DCR-AUD in Healthy Volunteers". DCR-AUD will be evaluated for safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy volunteers.
What is the current status of trial NCT05021640?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2021-09-21. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT05021640?
The interventions under investigation include: DCR-AUD (DRUG), Placebo for DCR-AUD (DRUG).
Who is sponsoring clinical trial NCT05021640?
This trial is sponsored by Dicerna Pharmaceuticals, Inc., a Novo Nordisk company, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.